These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 12009005)
1. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton. Stewart AF J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005 [TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors. Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004 [TBL] [Abstract][Full Text] [Related]
3. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-OcaƱa A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737 [TBL] [Abstract][Full Text] [Related]
4. Humoral hypercalcemia of malignancy: some enigmas on the clinical features. Ikeda K; Ogata E J Cell Biochem; 1995 Mar; 57(3):384-91. PubMed ID: 7768974 [TBL] [Abstract][Full Text] [Related]
5. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357 [TBL] [Abstract][Full Text] [Related]
6. [Malignancy-associated hypercalcemia]. Yamaguchi K Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737 [TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide. Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119 [TBL] [Abstract][Full Text] [Related]
8. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein. Insogna KL Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773 [TBL] [Abstract][Full Text] [Related]
9. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. Nakayama K; Fukumoto S; Takeda S; Takeuchi Y; Ishikawa T; Miura M; Hata K; Hane M; Tamura Y; Tanaka Y; Kitaoka M; Obara T; Ogata E; Matsumoto T J Clin Endocrinol Metab; 1996 Feb; 81(2):607-11. PubMed ID: 8636276 [TBL] [Abstract][Full Text] [Related]
10. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia]. Okazaki R Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates and primary hyperparathyroidism. Rodan GA J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793 [TBL] [Abstract][Full Text] [Related]
12. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM). Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809 [TBL] [Abstract][Full Text] [Related]
13. Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy. Ralston SH; Boyce BF; Cowan RA; Gardner MD; Fraser WD; Boyle IT J Bone Miner Res; 1989 Feb; 4(1):103-11. PubMed ID: 2718773 [TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas. Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481 [TBL] [Abstract][Full Text] [Related]
15. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Chattopadhyay N Am J Physiol Endocrinol Metab; 2006 May; 290(5):E761-70. PubMed ID: 16603723 [TBL] [Abstract][Full Text] [Related]
16. [Malignant humoral hypercalcemia and the parathyroid hormone related protein]. Jemtland R; Rian E; Gautvik KM Tidsskr Nor Laegeforen; 1991 May; 111(14):1738-42. PubMed ID: 2063384 [TBL] [Abstract][Full Text] [Related]
17. A novel parathyroid hormone-related protein: role in pathology and physiology. Martin TJ; Ebeling PR Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438 [TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia of malignancy--new insights into an old syndrome. Esbrit P Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225 [TBL] [Abstract][Full Text] [Related]
19. PTHrP and PTH/PTHrP receptor 1 expression in odontogenic cells of normal and HHM model rat incisors. Kato A; Suzuki M; Karasawa Y; Sugimoto T; Doi K Toxicol Pathol; 2005; 33(4):456-64. PubMed ID: 16036863 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]